CoagCare Platform

01 / FAST

Less than 5-10 minutes 

from insertion of sample (approx. 20 microliters) to

full viscoelastic curve and parameter generation

02 / PORTABLE

Low-cost, single-use diagnostic test strips that interface with a wireless, handheld meter that is vibration-insensitive

03 / ACCURATE

Highly accurate, mechanical viscoelasticity and density measurement for blood coagulation diagnostics

CoagCare / PLATFORM CAPABILITIES*

 

  • Thromboelastography

    • Clot Formation Time​

    • Clot Stiffness (Fibrinogen)

    • Platelet Activity

    • Fibrinolysis

  • Thrombin Generation Assay

  • Direct Oral Anticoagulants (DOAC) Monitoring (including Factor IIa and Xa drug differentiation)

  • Prothrombin Time (PT) / International Normalized Ratio (INR)

  • Hematocrit (Hct)

  • Activated Partial Thromboplastin Time (aPTT)

  • Low- and High-range Activated Clotting Time (ACT)

 

* feasibility demonstrated ​on clinical & analytical blood samples

 
 

COVID-19

Coagulopathy is a major cause of death in COVID-19 patients

Viscoelastic tests can accurately detect and manage Coagulopathy

Critical need for fast, point-of-care (POC) viscoelastic tests to:

  • Quickly screen for coagulopathy in asymptomatic and symptomatic COVID-19 patients.
     

  • Provide closed-loop therapeutic management in ambulatory, inpatient and outpatient settings.​

 
 

GET IN TOUCH

CONTACT US

© 2020 by Abram Scientific, Inc. All rights reserved. No portion of this site may be copied or reused without permission. This site contains material, including, without limitation, text, graphics and images, which we may own or may be made available to us through arrangements with third-parties. Abram’s products, including any in vitro diagnostic products referenced herein, are intended for investigational use only. They are not for commercial sale and are not for clinical diagnostic use. The claims made on this site have not been evaluated by the United States Food and Drug Administration or any comparable regulatory authority in jurisdictions outside the United States.